ArticleCureus2024
Beyond Ischemia: The Rare Occurrence of Hemorrhagic Strokes in Pediatric Sickle Cell Anemia.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neurological manifestations in Nigerian children with sickle cell disease: a single-center retrospective study.BMC pediatrics · 2026Article
- Timely surgical intervention in sickle cell-related hemorrhagic stroke: a pediatric success story and literature review.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sickle cell anemia (SCA) is a genetic disorder characterized by the production of abnormal hemoglobin S, leading to red blood cell sickling and subsequent vaso-occlusive events. Neurological complications, particularly strokes, significantly contribute to the morbidity and mortality associated with SCA. While ischemic strokes are more common, hemorrhagic strokes, though less frequent, present significant challenges, especially in the pediatric population. Understanding the complex interplay of genetic, environmental, and hematological factors is crucial for managing these cases. We report two cases of pediatric patients with SCA who experienced rare hemorrhagic strokes. The first case involves a nine-year-old male presenting with a subarachnoid hemorrhage, revealing cortical ischemia and multiple cerebral artery strictures. Early supportive measures resulted in a good clinical improvement, after which the patient underwent bone marrow transplantation. The second case describes a seven-year-old male who developed an epidural hematoma during a vaso-occlusive crisis, necessitating emergency surgical intervention. After initial persistent neurological deficits, the patient began to show gradual improvement with ongoing management, reflecting the complexity and severity of such events. Hemorrhagic strokes in pediatric SCA patients, though rare, represent significant clinical challenges due to their multifactorial etiology and complex management needs. These cases underscore the importance of a multidisciplinary approach and advanced diagnostic tools in managing hemorrhagic complications in SCA. Further research is essential to unravel the pathophysiological mechanisms and develop targeted prevention strategies to improve outcomes for this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.